• Contemporary ClinicContemporary Clinic
  • OTC GuideOTC Guide
  • Pharmacy Times
  • PTCEPTCE
  • Pharmacist Moms GroupPharmacist Moms Group
News
All News
FDA Updates
Press Releases
Media
All Videos
Digital Detail
Independent Corner
Insights
Interviews
MEDcast
Medical World News
Microsites
Peer Exchange
Perfect Consult
Podcasts
Practice Pearls
Sponsored Webcast
Student Voices
Webinars/Webcasts
Conferences
Conference Coverage
Conference Listing
Publications
Pharmacy Times
Pharmacy Practice in Focus: Oncology
Pharmacy Practice in Focus: Health Systems
Pharmacy Careers
All Publications
About the Publications
Author Submission
Submit to Pharmacy Practice in Focus: Oncology
Submit to Pharmacy Practice in Focus: Health Systems
Become a Peer Reviewer
Supplements & Featured Publications
Clinical
503B Compounding Pharmacy
ADHD
Allergy
Alzheimer Disease
Anxiety
Asthma
Atopic Dermatitis
Biosimilars
Bipolar Disorder
Brain Health
Breast Cancer
C. Difficile
COPD
COVID-19
Cardiovascular Health
Cervical Cancer
Cholangiocarcinoma
Cholesterol
Chronic Kidney Disease
Chronic Lymphocytic Leukemia
Classical Hematology
Colorectal Cancer
Continuous Glucose Monitoring
Cough and Cold
Depression
Dermatology
Diabetes
Digestive Health
Dry Eye Disease
Epilepsy
Eye Care
Flu
Future of Pharmacy
Gastrointestinal Cancer
Gastrointestinal Health
Gout
HER2 Breast Cancer
HIV
Heart Failure
Hematology
Hepatitis/MASH
Immunization
Immuno-oncology
Immunoglobulins
Infectious Disease
Lung Cancer
Lymphoma
Macular Degeneration
Mental Health
Migraine
Movement Disorders
Multiple Myeloma
Multiple Sclerosis
Myelofibrosis
Neurology
Neutropenia
Osteoporosis
Ovarian Cancer
Pain Management
Parkinson Disease
Pediatrics
Pharmacy Heroes
Pharmacy Management
Pneumococcal
PrEP
Prostate Cancer
Psoriasis
Psoriatic Arthritis
Psychedelics
Reimbursement
Reproductive Health
Respiratory Syncytial Virus
Rheumatoid Arthritis
Schizophrenia
Shingles
Skin Cancer
Sleep
Travel Vaccines
Veterinary Pharmacy
Vitamins and Supplements
Weight Management
Women's Health
Events
Upcoming Events
Upcoming Webinars
CE
Resources
Clinical Forum
Educated Patient
Information for the Pharmacist
Interactive Tools
Partners
Sponsored
Whiteboards
Subscribe
logo
Spotlight
Community/RetailHospitalOncologyPharmacy TechnicianStudent
Clinical Role
Community/RetailHospitalOncologyPharmacy TechnicianSpecialty PharmacyStudent
Clinical
CoronavirusBrain HealthCardiovascular HealthDermatologyDiabetesFluHeart FailureHepatitis/MASHImmunizationMigrainePneumococcalVitamins and Supplements
Supplement Spotlight
October 2023 Pharmacy Technician Edition
All News
FDA Updates
Press Releases
All Videos
Digital Detail
Independent Corner
Insights
Interviews
MEDcast
Medical World News
Microsites
Peer Exchange
Perfect Consult
Podcasts
Practice Pearls
Sponsored Webcast
Student Voices
Webinars/Webcasts
Conference Coverage
Conference Listing
Pharmacy Times
Pharmacy Practice in Focus: Oncology
Pharmacy Practice in Focus: Health Systems
Pharmacy Careers
All Publications
About the Publications
Author Submission
Submit to Pharmacy Practice in Focus: Oncology
Submit to Pharmacy Practice in Focus: Health Systems
Become a Peer Reviewer
Supplements & Featured Publications
503B Compounding Pharmacy
ADHD
Allergy
Alzheimer Disease
Anxiety
Asthma
Atopic Dermatitis
Biosimilars
Bipolar Disorder
Brain Health
Breast Cancer
C. Difficile
COPD
COVID-19
Cardiovascular Health
Cervical Cancer
Cholangiocarcinoma
Cholesterol
Chronic Kidney Disease
Chronic Lymphocytic Leukemia
Classical Hematology
Colorectal Cancer
Continuous Glucose Monitoring
Cough and Cold
Depression
Dermatology
Diabetes
Digestive Health
Dry Eye Disease
Epilepsy
Eye Care
Flu
Future of Pharmacy
Gastrointestinal Cancer
Gastrointestinal Health
Gout
HER2 Breast Cancer
HIV
Heart Failure
Hematology
Hepatitis/MASH
Immunization
Immuno-oncology
Immunoglobulins
Infectious Disease
Lung Cancer
Lymphoma
Macular Degeneration
Mental Health
Migraine
Movement Disorders
Multiple Myeloma
Multiple Sclerosis
Myelofibrosis
Neurology
Neutropenia
Osteoporosis
Ovarian Cancer
Pain Management
Parkinson Disease
Pediatrics
Pharmacy Heroes
Pharmacy Management
Pneumococcal
PrEP
Prostate Cancer
Psoriasis
Psoriatic Arthritis
Psychedelics
Reimbursement
Reproductive Health
Respiratory Syncytial Virus
Rheumatoid Arthritis
Schizophrenia
Shingles
Skin Cancer
Sleep
Travel Vaccines
Veterinary Pharmacy
Vitamins and Supplements
Weight Management
Women's Health
Upcoming Events
Upcoming Webinars
CE
Clinical Forum
Educated Patient
Information for the Pharmacist
Interactive Tools
Partners
Sponsored
Whiteboards
Subscribe
Advertisement

CLINICAL ROLE -

Community/Retail
| Hospital
| Oncology
| Pharmacy Technician
| Student

Article

October 20, 2016

Trending News Today: Monthly Health Insurance Enrollment Predicted to Rise

Author(s):

Laurie Toich, Assistant Editor

Top news of the day from across the healthcare landscape.

A recent study found that in the first 2 years of Oregon’s Medicaid expansion, emergency department use remained high, and more patients were visiting doctor’s offices. Oregon expanded their Medicaid program through a lottery that granted certain patients coverage. Despite high hospitalization rates in the first few years, more patients were financially secure, they went to primary care physicians, and depression rates decreased, according to Kaiser Health News.

The emergence of biosimilars has provided a potential way to reduce healthcare costs, since these biologic drugs typically cost 80% less than their reference product. However, Inflectra is being sold for 15% less than its reference product, Remicade, for the treatment of rheumatoid arthritis. NPR reported that the 15% discount is still significant, and will provide the biosimilar at the 2014 price of Remicade.

The federal government is predicting monthly health insurance enrollment to increase to 11.4 million during open enrollment this coming year. Regardless of increasing premiums and insurers leaving the Affordable Care Act marketplaces, this comprises a 9% total increase from 2016, according to The New York Times. Overall, the government expects 13.8 million people to enroll.

Newsletter

Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.

Subscribe Now!
Related Videos
Image credit: Photo18@desing | stock.dobe.com
Related Content
Advertisement
Adalimumab (Humira) biosimilar (Hyrimoz) -- Image credit: luchschenF | stock.adobe.com
August 28th 2025

Switching From Reference Adalimumab to Biosimilar Shows No Major Differences in Patients With RA, PsA

Gillian McGovern, Associate Editor
Pharmacy Focus: AMCP Nexus 2023 - Recap on Biosimilar Updates
August 28th 2025

Pharmacy Focus: AMCP Nexus 2023 - Recap on Biosimilar Updates

GLP-1 dulaglutide (Trulicity) -- Image credit: Edugrafo | stock.adobe.com
August 28th 2025

Dulaglutide Biosimilar Achieves Equivalent Efficacy in HbA1c Reduction in Patients With T2DM

Gillian McGovern, Associate Editor
Pharmacist Moms: Coffee With Suzy - Episode 19
August 28th 2025

Pharmacist Moms: Coffee With Suzy - Episode 19

Navigating Biosimilars and 505(b)(2) Drugs in Oncology: Operational, Clinical, and Policy Strategies for Pharmacists
August 28th 2025

Navigating Biosimilars and 505(b)(2) Drugs in Oncology: Operational, Clinical, and Policy Strategies for Pharmacists

Alana Hippensteele, Lead Editor
Blood sample for Cytokine test, used to pathophysiology of immune, infectious, or inflammatory disorders. Cytokine Release Syndrome - Image credit: MdBabul | stock.adobe.com
August 28th 2025

FDA Approves Expanded Indication to Tocilizumab-Anoh IV for CRS

Kennedy Ferruggia, Assistant Editor
Related Content
Advertisement
Adalimumab (Humira) biosimilar (Hyrimoz) -- Image credit: luchschenF | stock.adobe.com
August 28th 2025

Switching From Reference Adalimumab to Biosimilar Shows No Major Differences in Patients With RA, PsA

Gillian McGovern, Associate Editor
Pharmacy Focus: AMCP Nexus 2023 - Recap on Biosimilar Updates
August 28th 2025

Pharmacy Focus: AMCP Nexus 2023 - Recap on Biosimilar Updates

GLP-1 dulaglutide (Trulicity) -- Image credit: Edugrafo | stock.adobe.com
August 28th 2025

Dulaglutide Biosimilar Achieves Equivalent Efficacy in HbA1c Reduction in Patients With T2DM

Gillian McGovern, Associate Editor
Pharmacist Moms: Coffee With Suzy - Episode 19
August 28th 2025

Pharmacist Moms: Coffee With Suzy - Episode 19

Navigating Biosimilars and 505(b)(2) Drugs in Oncology: Operational, Clinical, and Policy Strategies for Pharmacists
August 28th 2025

Navigating Biosimilars and 505(b)(2) Drugs in Oncology: Operational, Clinical, and Policy Strategies for Pharmacists

Alana Hippensteele, Lead Editor
Blood sample for Cytokine test, used to pathophysiology of immune, infectious, or inflammatory disorders. Cytokine Release Syndrome - Image credit: MdBabul | stock.adobe.com
August 28th 2025

FDA Approves Expanded Indication to Tocilizumab-Anoh IV for CRS

Kennedy Ferruggia, Assistant Editor
Consent Preferences
About Us
Clinical Forums
Advertise
Contact Us
Editorial Staff
Privacy Policy
Terms & Conditions
Do Not Sell My Information
Contact Info

2 Commerce Drive
Cranbury, NJ 08512

609-716-7777

© 2025 MJH Life Sciences

All rights reserved.